RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 November 2009
Ann Clin Biochem 2009;46:488-494
doi:10.1258/acb.2009.009002
© 2009 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
acb.2009.009002v1
46/6/488    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Goldshtein, H.
Right arrow Articles by Douvdevani, A.
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Articles

A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids

Hagit Goldshtein1, Michael J Hausmann2 and Amos Douvdevani1,2


1 Department of Clinical Biochemistry, Ben-Gurion University of the Negev; 2 Department of Nephrology, Soroka Medical University Center, Beer-Sheva, Israel


Corresponding author: Amos Douvdevani, Nephrology Laboratory, Soroka Medical Center, Sderot Rager, P.O. Box 151, Beer-Sheva 84101, Israel. Email: amosd{at}bgu.ac.il


Background: Circulating cell-free DNA (CFD) levels may be elevated in trauma, stroke, sepsis, pre-eclampsia and cancer. Owing to the complex and expensive methodology, detection of CFD has hitherto been confined to research laboratories. This study presents a simple, inexpensive and accurate test for CFD.

Methods: Using the commercial fluorescent SYBR® Gold stain, biological fluids were directly assayed for CFD without prior DNA extraction and amplification. Stain was added to the sample in 96-well plates (final stain dilution: 1:10,000) and fluorescence was read by a fluorometer (excitation wavelength 488 nm, emission wavelength 535 nm).

Results: The assay was validated with serum, whole blood, urine and supernatant of cell cultures. Specificity and linearity were demonstrated over a wide range of concentrations; the results correlated with the conventional quantitative polymerase chain reaction assay of β-globin (R2 = 0.9987, P < 0.001). The assay was not affected by exposure of whole blood or serum to room temperature for four or 24 h, respectively. Intra and day-to-day coefficients of variation (16–4.8% and 31–8%, respectively; depending on DNA level) compared well with published data describing more work-intensive tests. The limit of quantitation (170 ng/mL) was below the mean DNA level in a cohort of normal individuals (471 [203] ng/mL). Finally, free DNA in supernatant of cell cultures after cell lysis accurately reflected cell number (R2 = 0.974, P < 0.0001).

Conclusions: The direct SYBR® Gold assay proved to be an accurate and simple technique for measuring CFD in biological fluids.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




How Not to be a Doctor